$MNKD Just listened to United Therapeutic presentation at the Bernstein Conference held yesterday and Martine said drug launches will start with
#1 & 2 for Nebulize Tyvaso for IPF and PPF and then
#3 and
#4 for Tyvaso DPI for IPF and PPF. She said Tyvaso DPI is already approved and the
#1 product prescribed in PH-ILD. Martine added following launches
#1, 2, 3 & 4 United plans to launches
#5, 6 & 7 for softmist Trezmi, for ILD, IPF, PPF. Martine was asked which program does she believe in most important and said Ralinepag which she believes will be their top product. MNKD currently working on Ralinepag DPI for PAH, PH-ILD, IPF & PPF. My take away Technosphere DPI will play a critical role in the future growth of United Therapeutic that Martine expects could reach $100 billion in revenues and MNKD will benefit greatly from it either is significant royalties they will receive or if they choose, sell Tyvaso DPI and Ralinepag DPI rights to United Therapeutic in a huge billion dollar deal